MIRA Stock Summary and Trading Ideas (Mira Pharmaceuticals | NASDAQ:MIRA)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Mira Pharmaceuticals trades on the NASDAQ stock market under the symbol MIRA.

As of February 3, 2026, MIRA stock price declined to $1.19 with 132,597 million shares trading.

MIRA has a beta of 1.98, meaning it tends to be more sensitive to market movements. MIRA has a correlation of 0.19 to the broad based SPY ETF.

MIRA has a market cap of $49.83 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that MIRA belongs to (by Net Assets): VXF, VTI.

MIRA has underperformed the market in the last year with a price return of +2.6% while the SPY ETF gained +16.6%. MIRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.0% and -17.9%, respectively, while the SPY returned +1.2% and +1.8%, respectively.

MIRA support price is $1.16 and resistance is $1.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIRA shares will trade within this expected range on the day.